4.6 Article

Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy in Japanese Cohort

Journal

AMERICAN JOURNAL OF OPHTHALMOLOGY
Volume 168, Issue -, Pages 86-94

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2016.04.023

Keywords

-

Categories

Funding

  1. JSPS KAKENHI [25462709, 25462738, 30255525, 26462674]
  2. Japan Agency for Medical Research and Development (AMED) [15ek0109072h0002]
  3. Santen Pharmaceutical Co, Ltd, Japan
  4. Novartis Pharma K.K., Japan
  5. Bayer Yakuhin, Ltd, Japan
  6. Pfizer Japan Inc
  7. Senju Pharmaceutical Co, Ltd, Japan
  8. Abbott Medical Optics Inc, Japan
  9. Wakamoto Pharmaceutical Co, Ltd, Japan
  10. R-Tech Ueno, Ltd., Japan
  11. Alcon Japan Ltd, Japan
  12. DAIICHI SANKYO COMPANY, LIMITED, Japan
  13. Mitsubishi Tanabe Pharma Corporation, Japan
  14. HOYA CORPORATION, Japan
  15. NIDEK CO, LTD, Japan
  16. Otsuka Pharmaceutical Co, Ltd, Japan
  17. MSD K.K., Japan
  18. KOWA PHARMACEUTICAL COMPANY LTD, Japan
  19. Pfizer Japan Inc, Japan
  20. WAKAMOTO Co, Ltd, Japan
  21. Grants-in-Aid for Scientific Research [26462674, 25462738] Funding Source: KAKEN

Ask authors/readers for more resources

PURPOSE: To report the clinical and genetic findings of 9 Japanese patients with autosomal recessive bestrophinopathy (ARB). DESIGN: Retrospective, multicenter observational case series. METHODS: Nine ARB patients from 7 unrelated Japanese families that were examined in 3 institutions in Japan were studied. A series of ophthalmic examinations including fundus photography, spectral-domain optical coherence tomography, fundus autofluorescence, electrooculography (EOG), electroretinography, and the results of genetic analysis were reviewed. RESULTS: Genetic analyses identified 7 pathogenic variants in BEST1 including 2 novel variants, c.478G > C (p.A160P) and c.948 + 1delG. Homozygous variants were found in 4 families and compound heterozygous variants were found in 3 families. Two patients were diagnosed as ARB only after the whole exome sequencing analyses. The Arden ratio of the EOG was less than 1.5 in all 7 patients tested. Vitelliform lesions typical for Best vitelliform macular dystrophy were not seen in any of the patients. Seven patients shared some of the previously described features of ARB: subretinal deposits, extensive subretinal fluid, and cystoid macular edema (CME). However, the other 2 patients with severe retinal degeneration lacked these features. Focal choroidal excavations were present bilaterally in 2 patients. One case had a marked reduction of the CME and expansion of subretinal deposits over an 8-year of follow-up period. CONCLUSIONS: Japanese ARB patients had some but not all of the previously described features. Genetic analyses are essential to diagnose ARB correctly in consequence of considerable phenotypic variations. ((C) 2016 Elsevier Inc. All rights reserved.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available